Cancer Evolutionist: A Profile of Charles Swanton

Motivated by his father’s cancer diagnosis, the Francis Crick Institute cancer geneticist has been revealing the ways tumors evolve and why they are so difficult to treat.

Written byAnna Azvolinsky
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

CHARLES SWANTON
Chair, Personalised Cancer Medicine, University College London (UCL)
Co-Director, CR-UK UCL/Manchester Lung Cancer Centre of Excellence
Senior Group Leader, Translational Cancer Therapeutics Laboratory,
Francis Crick Institute
Stand Up 2 Cancer Laura Ziskin Translational Cancer Research Prize (2015)
Fondazione San Salvatore Award for Cancer Research (Lugano, 2017)
Cancer Research UK Translational Cancer Research Prize (2017)
THOMAS FARNETTI/WELLCOME IMAGES

In 1993, Charles Swanton’s clinical training was set to commence. He had just finished his preclinical work at St. Bartholomew’s and the Royal London Medical School when the 21-year-old opted to complete a yearlong cellular pathology program at University College London (UCL) Medical School and earn his bachelor’s degree.

There, learning about prior discoveries in cell biology from his professors, Swanton got a taste for the pursuit of scientific discovery. “I vividly remember the first lecture. The professor was setting up the overhead projector and slides, and I was preparing for two hours of tedium. Then, 30 minutes into telling us about how cells move, I was completely mesmerized,” recalls Swanton, now a cancer researcher at the Francis Crick Institute in London. The experience changed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile

Published In

April 2018

Neuron Nets

Wrapped up in memory, addiction, and more

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies